AR018113A1 - Composicion farmaceutica que comprende un inhibidor de mmp y una estatina, primera composicion farmaceutica para su uso con una segunda composicionfarmaceutica para lograr un efecto hipolipidemico en un mamifero que sufre hiperlipidemia y conjunto para lograr dicho efecto - Google Patents
Composicion farmaceutica que comprende un inhibidor de mmp y una estatina, primera composicion farmaceutica para su uso con una segunda composicionfarmaceutica para lograr un efecto hipolipidemico en un mamifero que sufre hiperlipidemia y conjunto para lograr dicho efectoInfo
- Publication number
- AR018113A1 AR018113A1 ARP990100751A ARP990100751A AR018113A1 AR 018113 A1 AR018113 A1 AR 018113A1 AR P990100751 A ARP990100751 A AR P990100751A AR P990100751 A ARP990100751 A AR P990100751A AR 018113 A1 AR018113 A1 AR 018113A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutically acceptable
- pharmaceutical composition
- statin
- mmp inhibitor
- amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7826598P | 1998-03-17 | 1998-03-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR018113A1 true AR018113A1 (es) | 2001-10-31 |
Family
ID=22142950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990100751A AR018113A1 (es) | 1998-03-17 | 1999-02-24 | Composicion farmaceutica que comprende un inhibidor de mmp y una estatina, primera composicion farmaceutica para su uso con una segunda composicionfarmaceutica para lograr un efecto hipolipidemico en un mamifero que sufre hiperlipidemia y conjunto para lograr dicho efecto |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1063991A1 (ko) |
| JP (1) | JP2002506818A (ko) |
| KR (1) | KR20010041916A (ko) |
| AR (1) | AR018113A1 (ko) |
| AU (1) | AU1591699A (ko) |
| BR (1) | BR9815745A (ko) |
| CA (1) | CA2309588A1 (ko) |
| CO (1) | CO5070670A1 (ko) |
| GT (1) | GT199900039A (ko) |
| HN (1) | HN1999000029A (ko) |
| MY (1) | MY140504A (ko) |
| NZ (1) | NZ505994A (ko) |
| PA (1) | PA8469001A1 (ko) |
| PE (1) | PE20000348A1 (ko) |
| SV (1) | SV1999000026A (ko) |
| UY (1) | UY25436A1 (ko) |
| WO (1) | WO1999047138A1 (ko) |
| ZA (1) | ZA992106B (ko) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
| RU2410118C2 (ru) | 2004-12-15 | 2011-01-27 | Зольвай Фармасьютиклз Гмбх | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, ВКЛЮЧАЮЩИЕ ИНГИБИТОРЫ НЭП (НЕЙТРАЛЬНОЙ ЭНДОПЕПТИДАЗЫ), ИНГИБИТОРЫ ЭНДОГЕННОЙ ПРОДУЦИРУЮЩЕЙ ЭНДОТЕЛИН СИСТЕМЫ И ИНГИБИТОРЫ ГМГ (ГИДРОКСИМЕТИЛГЛУТАРИЛ)СоА РЕДУКТАЗЫ |
| SG166829A1 (en) * | 2005-11-08 | 2010-12-29 | Ranbaxy Lab Ltd | Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
| WO2010005389A1 (en) * | 2008-07-11 | 2010-01-14 | Forskarpatent I Syd Ab | Oxidized ldl specific antibody-fusion and conjugated proteins |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9611410A (pt) * | 1995-11-02 | 1999-01-05 | Warner Lambert Co | Método e composição farmacêutica para regular a concentração de lipídios |
| PL186416B1 (pl) * | 1996-05-17 | 2004-01-30 | Warner Lambert Co | Związek bifenylosulfonamidowy i preparat farmaceutyczny zawierający ten związek |
| IL128545A0 (en) * | 1996-12-09 | 2000-01-31 | Warner Lambert Co | Method for treating and preventing heart failure and ventricular dilatation |
| TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
| GT199800126A (es) * | 1997-08-29 | 2000-01-29 | Terapia de combinacion. |
-
1998
- 1998-11-20 EP EP98960279A patent/EP1063991A1/en not_active Withdrawn
- 1998-11-20 JP JP2000536378A patent/JP2002506818A/ja active Pending
- 1998-11-20 NZ NZ505994A patent/NZ505994A/xx unknown
- 1998-11-20 CA CA002309588A patent/CA2309588A1/en not_active Abandoned
- 1998-11-20 KR KR1020007010223A patent/KR20010041916A/ko not_active Application Discontinuation
- 1998-11-20 AU AU15916/99A patent/AU1591699A/en not_active Abandoned
- 1998-11-20 WO PCT/US1998/024681 patent/WO1999047138A1/en not_active Application Discontinuation
- 1998-11-20 BR BR9815745-0A patent/BR9815745A/pt not_active Application Discontinuation
-
1999
- 1999-02-24 AR ARP990100751A patent/AR018113A1/es unknown
- 1999-03-15 MY MYPI99000951A patent/MY140504A/en unknown
- 1999-03-16 HN HN1999000029A patent/HN1999000029A/es unknown
- 1999-03-16 SV SV1999000026A patent/SV1999000026A/es not_active Application Discontinuation
- 1999-03-16 PA PA19998469001A patent/PA8469001A1/es unknown
- 1999-03-16 UY UY25436A patent/UY25436A1/es not_active Application Discontinuation
- 1999-03-16 CO CO99016109A patent/CO5070670A1/es unknown
- 1999-03-16 ZA ZA9902106A patent/ZA992106B/xx unknown
- 1999-03-16 PE PE1999000217A patent/PE20000348A1/es not_active Application Discontinuation
- 1999-03-16 GT GT199900039A patent/GT199900039A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PA8469001A1 (es) | 2002-09-17 |
| AU1591699A (en) | 1999-10-11 |
| CA2309588A1 (en) | 1999-09-23 |
| BR9815745A (pt) | 2000-11-14 |
| NZ505994A (en) | 2003-10-31 |
| JP2002506818A (ja) | 2002-03-05 |
| SV1999000026A (es) | 2000-01-18 |
| UY25436A1 (es) | 2001-10-25 |
| CO5070670A1 (es) | 2001-08-28 |
| GT199900039A (es) | 2000-09-06 |
| HN1999000029A (es) | 1999-09-29 |
| KR20010041916A (ko) | 2001-05-25 |
| ZA992106B (en) | 1999-09-30 |
| MY140504A (en) | 2009-12-31 |
| WO1999047138A1 (en) | 1999-09-23 |
| EP1063991A1 (en) | 2001-01-03 |
| PE20000348A1 (es) | 2000-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9204268A (es) | Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma. | |
| ES2545205T3 (es) | Combinación de azelastina y ciclesonida | |
| BR9803300A (pt) | Formulação farmacêutica. | |
| EA199700266A1 (ru) | Фармацевтическая композиция, содержащая выбранные гидраты карбоната лантана | |
| BR0111667A (pt) | Novos compostos | |
| BR0002898A (pt) | Aplicador de doses de lìquido que possui um dispositivo para contar as doses ministradas | |
| CL2012001063A1 (es) | Anticuerpo humano que se une a interleuquina 18 humana (il-18h), metodo de preparacion, acidos nucleicos que lo dosifican, composicion que los contiene, uso en la preparacion de un medicamento para tratar patologias mediadas por il-18h. (divisional sol. 316-01). | |
| BR9909565A (pt) | Derivados bicìclicos do ácido hidroxâmico | |
| AR030570A1 (es) | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de colesteril ester | |
| ES2176684T3 (es) | Nuevas asociaciones de principios activos que contienen clopidogrel y un antitrombotico. | |
| AR036781A1 (es) | Una composicion para un material para la construccion y material para la construccion | |
| AR034898A1 (es) | Composicion cristalina que contiene escitalopram | |
| DK1156806T3 (da) | Farmaceutisk sammensætning indeholdende protonpumpeinhibitor | |
| BR9909138A (pt) | Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda | |
| PA8506301A1 (es) | Cristal de 4- carboxamino- 1,2,3,4,- tetrahidroquinolina 2-sustituida | |
| ATE252885T1 (de) | Plan zur verabreichung von h+, k+-atpase inhibitoren | |
| AR047191A1 (es) | Metodos de tratamiento de fibrosis hepatica | |
| FR2848116B1 (fr) | Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide. | |
| ES2191987T3 (es) | Formas de dosificacion de ribavirina solidas, administrables oralmente, y procedimiento de fabricacion. | |
| ATE273699T1 (de) | Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie | |
| BR0213181A (pt) | Combinações de inibidor de cox-2 | |
| AR018113A1 (es) | Composicion farmaceutica que comprende un inhibidor de mmp y una estatina, primera composicion farmaceutica para su uso con una segunda composicionfarmaceutica para lograr un efecto hipolipidemico en un mamifero que sufre hiperlipidemia y conjunto para lograr dicho efecto | |
| BR9915215A (pt) | Composição farmacêutica para liberação modificada de sensibilizador de insulina | |
| ES2117272T3 (es) | Composiciones farmaceuticas orales que comprenden una proteina o peptido, un anticuerpo y esferas polimericas. | |
| ES2105605T3 (es) | Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |